68 related articles for article (PubMed ID: 1130738)
1. Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.
Malit LA; Johnstone RE; Bourke DI; Kulp RA; Klein V; Smith TC
Anesthesiology; 1975 Jun; 42(6):666-73. PubMed ID: 1130738
[TBL] [Abstract][Full Text] [Related]
2. Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics.
Johnstone RE; Lief PL; Kulp RA; Smith TC
Anesthesiology; 1975 Jun; 42(6):674-84. PubMed ID: 48348
[TBL] [Abstract][Full Text] [Related]
3. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
Khiabani HZ; Mørland J; Bramness JG
Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
[TBL] [Abstract][Full Text] [Related]
4. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.
Adams MD; Earnhardt JT; Dewey WL; Harris LS
J Pharmacol Exp Ther; 1976 Mar; 196(3):649-56. PubMed ID: 4606
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
Lemberger L; Martz R; Rodda B; Forney R; Rowe H
J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
[TBL] [Abstract][Full Text] [Related]
6. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.
Fredericks AB; Benowitz NL; Savanapridi CY
J Pharmacol Exp Ther; 1981 Feb; 216(2):247-53. PubMed ID: 6257883
[TBL] [Abstract][Full Text] [Related]
7. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and respiratory effects of cannabis extracts and 1-tetra-hydrocannabinol ( 1-THC).
Li DM
Br J Pharmacol; 1973 Mar; 47(3):627P. PubMed ID: 4147195
[No Abstract] [Full Text] [Related]
9. Certain observations on interrelationships between respiratory and cardiovascular effects of (-)- 9 -trans-tetrahydrocannabinol.
Cavero I; Kubena RK; Dziak J; Buckley JP; Jandhyala BS
Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):483-92. PubMed ID: 5034510
[No Abstract] [Full Text] [Related]
10. Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man.
Purnell WD; Gregg JM
Ann Ophthalmol; 1975 Jul; 7(7):921-3. PubMed ID: 1147519
[TBL] [Abstract][Full Text] [Related]
11. Acute cardiovascular effects of delta-9-tetrahydrocannabinol in pregnant anesthetized sheep.
Cotterill RW; Penney LL; Vaughn DL; Reimann BE; Rauls DO
Biol Res Pregnancy Perinatol; 1984; 5(1):1-5. PubMed ID: 6322873
[TBL] [Abstract][Full Text] [Related]
12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic administration of delta9-tetrahydrocannabinol on the heart rate of mongrel dogs.
Jandhyala BS; Malloy KP; Buckley JP
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):201-4. PubMed ID: 935652
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
15. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
[TBL] [Abstract][Full Text] [Related]
16. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and respiratory effects of cannabis in cat and rat.
Graham JD; Li DM
Br J Pharmacol; 1973 Sep; 49(1):1-10. PubMed ID: 4787563
[TBL] [Abstract][Full Text] [Related]
18. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM
J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447
[TBL] [Abstract][Full Text] [Related]
19. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
Makela VH; Kapur PA
Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
